Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
MIP-PNP refers to a Molecularly Imprinted Polymer designed for selective recognition of 6-mercaptopurine (6-MP). This advanced material utilizes cross-linking polymerization with functional monomers and a porogen. The core structure relies on specific cavities matching the template molecule.
Store in a cool, dry place away from direct sunlight. Handle with appropriate PPE to avoid skin contact or inhalation of dust. Ensure compatibility with organic solvents during regeneration cycles.